Search

Your search keyword '"Sattler, B"' showing total 573 results

Search Constraints

Start Over You searched for: Author "Sattler, B" Remove constraint Author: "Sattler, B"
573 results on '"Sattler, B"'

Search Results

2. [18F]FLUDA – A promising PET probe for the non-invasive assessment of the A2A adenosine receptor

3. Combined PET/MRI: Global Warming—Summary Report of the 6th International Workshop on PET/MRI, March 27–29, 2017, Tübingen, Germany

6. [18F]FLUDA – A promising PET probe for the non-invasive assessment of the A2A adenosine receptor

8. Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17–21, 2014, Tübingen, Germany

12. Quantitation of the A2A adenosine receptor density in the striatum of mice and pigs with [18F]FLUDA by positron emission tomography

15. Quantitation of the A2A adenosine receptor density in the striatum of mice and pigs with [18F]FLUDA by positron emission tomography

17. Reproducibility of findings in modern PET neuroimaging:insight from the NRM2018 grand challenge

18. Quality control in PET/CT and PET/MRI: results of an EFOMP survey amongst Europe

23. [¹⁸F]FLUDA - A novel radiotracer for PET imaging of the adenosine A₂A receptor (A₂AR)

24. (+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand – Results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls

25. Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study

26. Quantification of cerebral nicotinic α7 acetylcholine receptors (α7 nAChRs) under gastric stimulation of the vagus nerve in piglets

29. Improved in vivo PET imaging of the adenosine A2A receptor in the brain using [18F]FLUDA, a deuterated radiotracer with high metabolic stability

30. Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study

33. Cold alpine regions.

38. High sigma-1 receptor (S1R) and very low dopamine 2/dopamine 3 receptor (D2/D3R) occupancy at clinically relevant doses of pridopidine in healthy volunteers (HV) and Huntington disease patients (HD): a F-18-Fluspidine and F-18-Fallypride PET study

40. Effect of Pridopidine in Huntington Disease (HD) Patients and Healthy Volunteers (HVs) – A Simultaneous Sigma-1 Receptor PET/Multimodality MRI Study

43. Preclinical incorporation dosimetry of [18F]FACH - a novel 18F-labeled MCT1/MCT4 lactate transporter inhibitor for imaging cancer metabolism with PET

48. Influence of APOE genotype on α4β2 nicotinic acetylcholine receptor binding in mild Alzheimer‘s dementia as assessed by (-)-[18F]Flubatine PET

49. Ring-up-doped fiber for the generation of more than 600 W single-mode narrow-band output at 1018 nm

Catalog

Books, media, physical & digital resources